Cookie Control

This site uses cookies to store information on your computer.

Some cookies on this site are essential, and the site won't work as expected without them. These cookies are set when you submit a form, login or interact with the site by doing something that goes beyond clicking on simple links.

We also use some non-essential cookies to anonymously track visitors or enhance your experience of the site. If you're not happy with this, we won't set these cookies but some nice features of the site may be unavailable.

By using our site you accept the terms of our Privacy Policy.

(One cookie will be set to store your preference)
(Ticking this sets a cookie to hide this popup if you then hit close. This will not store any personal information)

Antibiotic Resistance Could Cause Over 39 Million Deaths By 2050: Study

"Researchers have long flagged antimicrobial resistance as a public health concern, but this study is the first to analyze such trends around the world and over time."

"More than 39 million people could die of antibiotic-resistant infections between now and 2050, according to a study published Monday in The Lancet.

The authors of the study forecast a nearly 70 percent increase in deaths due to antimicrobial resistance from 2022 to 2050 with older people most at risk and driving the rise in fatalities. Such resistance, also known as AMR, occurs when microbes, such as bacteria and fungi, evolve in a way that makes them harder to kill with existing medications.

“It’s a big problem, and it is here to stay,” said Christopher J. L. Murray, senior author on the study and director of the Institute for Health Metrics and Evaluation at the University of Washington.

Researchers have flagged antimicrobial resistance as a public health concern for decades, but this study — conducted by a large team of researchers as part of the Global Research on Antimicrobial Resistance Project — is the first to analyze AMR trends around the world and over time. The World Health Organization says the threat of such antimicrobial resistance not only makes common infections harder to treat but makes medical interventions, such as chemotherapy and Caesarean sections, more risky."

Lizette Ortega reports for the Washington Post September 16, 2024.

Source: Washington Post, 09/18/2024